https://european-biotechnology.net/wp-content/uploads/2024/11/tk.de_ProBioGen_Cell_Line_AGE1.CR_.PIX_Kryolager_Resized.webp
541
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-05 17:09:512024-11-05 17:09:51Transgene and ProBioGen forge partnership
https://european-biotechnology.net/wp-content/uploads/2024/11/Semaglutide-e1730713859491.png
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-04 09:51:352024-11-04 09:51:35Novo’s obesity blockbuster semaglutide before label extension
https://european-biotechnology.net/wp-content/uploads/2024/11/Bracco–©-Niclas-Jessen-Studio_Bracco-Imaging-SpA-e1730446952949-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-11-01 07:43:442024-11-01 07:43:44Blue Therapeutics gets financing to push radiotherapies
https://european-biotechnology.net/wp-content/uploads/2024/10/Enifer_tg-e1729941718724-1030x579-1.png
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-31 08:46:502024-10-31 14:32:01Enifer files for EFSA authorisation of mycoprotein
https://european-biotechnology.net/wp-content/uploads/2024/10/Mayo-Clinic_Gonda_building.jpg
480
640
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-30 11:53:272024-10-30 11:53:27AIgnostics raises US$34m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/10/Antonio-Toniolo-CEO-of-Resalis-Therapeutics-1030x477-1.png
477
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-29 11:47:362024-10-29 11:47:36Resalis Therapeutics gets equity investment from Sanofi
https://european-biotechnology.net/wp-content/uploads/2024/10/UCB_HQ_Brussels.jpeg
294
922
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-28 06:59:122024-10-28 06:59:12Cancer UK/UCB collaboration: study with 2nd compound started
https://european-biotechnology.net/wp-content/uploads/2024/10/agomab_HGF-Aktivatorprotein.jpg
565
848
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-25 09:10:082024-10-30 10:32:01Agomab raises US$89m in Series D
https://european-biotechnology.net/wp-content/uploads/2024/10/Rentschler-Biopharma_150516_0186_Nukleus.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-24 05:30:102024-10-24 05:30:10Rentschler with double-digit investment in Germany
https://european-biotechnology.net/wp-content/uploads/2024/10/Roche3-1030x583-1.png
583
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-23 09:32:172024-10-23 09:32:17Roche leaves Alzheimer partnership with UCB
Scroll to top
